Search
Displaying results 21 - 21 of 21 in total
Lenvatinib Action Pathway
smpdb.ca/view/SMP0126908Drug actionIts approved indications include metastatic thyroid cancer, advanced renal cell carcinoma in combination with everolimus, and unresectable hepatocellular carcinoma.